Antigenic peptide loading onto class I MHC molecules in the endoplasmic reticulum requires the generation of peptides by the cytosolic proteasome and subsequent peptide transport into the endoplasmic reticulum. Dendritic cells express several endocytic receptors, including membrane lectins such as the mannose receptor and DC-SIGN (dendritic cell-specific ICAM-3-grabbing nonintegrin) that may be used to increase antigen presentation (2).
liter⅐mol
؊1 but have a very low affinity for DC-SIGN (less than 10 4 liter⅐mol ؊1 ). Conversely, Lewis clusters have a higher affinity toward DC-SIGN than toward the mannose receptor. Dimannoside clusters are efficiently taken up by human dendritic cells as well as by rat fibroblasts expressing the mannose receptor but not by HeLa cells or rat fibroblasts expressing DC-SIGN; DC-SIGN-expressing cells take up Lewis clusters. The results suggest that ligands containing dimannoside clusters can be used specifically to target the mannose receptor, whereas ligands containing Lewis clusters will be targeted to DC-SIGN.
Dendritic cells are efficient antigen-presenting cells central to cellular immune responses (1). Internalized antigens are
processed within the endosomal/lysosomal pathway for subsequent formation of MHC 1 class II peptide complexes. Dendritic cell vaccination to elicit cellular responses rather than humoral responses requires peptide presentation with MHC I. Antigenic peptide loading onto class I MHC molecules in the endoplasmic reticulum requires the generation of peptides by the cytosolic proteasome and subsequent peptide transport into the endoplasmic reticulum. Dendritic cells express several endocytic receptors, including membrane lectins such as the mannose receptor and DC-SIGN (dendritic cell-specific ICAM-3-grabbing nonintegrin) that may be used to increase antigen presentation (2) .
The mannose receptor, first characterized in macrophages (3), binds and takes up glycoproteins and glycoconjugates containing terminal mannose, GlcNAc, or fucose (4). Calcium-dependent recognition of these sugars is mediated by C-type carbohydrate recognition domains (CRDs) in the extracellular region of the receptor (5) . Glycoproteins internalized by the mannose receptor follow a well characterized endocytic pathway leading to lysosomes (6) . The cytoplasmic tail of the mannose receptor contains a tyrosine-based motif involved in the internalization process in association with clathrin-coated vesicles, and the mannose receptor traffics through early endosomes. Our experiments with fluorescein-labeled neoglycoproteins suggested that the mannose receptor is also expressed on monocyte-derived dendritic cells (7) , and this finding was subsequently confirmed (8) .
Recently, DC-SIGN, a new dendritic cell-specific membrane lectin was characterized (9) . DC-SIGN binds the gp120 envelope glycoprotein on the surface of human immunodeficiency virus-1 (10) . Its extracellular domain is a tetramer stabilized by an ␣-helical stalk, whereas its C-type CRDs bind high mannose oligosaccharides (11) . The presence of an internalization motif in its cytoplasmic tail suggests that DC-SIGN acts as an endocytic receptor, and it has been shown that complexes of DC-SIGN with an anti DC-SIGN antibody are targeted to late endosomes/lysosomes (12) . Therefore, in dendritic cells that express both the mannose receptor and DC-SIGN, the traffick-ing of an internalized glycosylated ligand will depend on its relative ability to bind each of these lectins.
In search of synthetic ligands suitable for use in human therapy, we selected chemically defined compounds that should have low molecular weight and be recognized by either the mannose receptor or DC-SIGN with high affinity. Accordingly, we developed sugar clusters using disaccharides (13, 14) . These small multivalent synthetic glycopeptides were made by coupling glycosynthons (diglycosylpyroglutamyl-␤-alanine derivatives (15)) onto a peptide containing up to five lysine residues. Such glycoclusters have previously been shown to bind various lectins with a high specificity. Glycoclusters containing lactose are taken up by HepG2 cells (13) , a human hepatoma cell line expressing the galactose-specific lectin (16) but not by dendritic cells, whereas those containing dimannosides are taken up avidly by dendritic cells but not by HepG2 cells (14) .
This study describes the use of a series of glycoclusters made of di-or oligosaccharides containing either mannose or fucose to identify the best ligands to allow selective recognition by either the mannose receptor or DC-SIGN. Surface plasmon resonance was used to determine glycocluster affinity for the purified lectins immobilized on sensor chips. Flow cytometry was used to examine glycocluster endocytosis by cells expressing either the mannose receptor or DC-SIGN.
EXPERIMENTAL PROCEDURES
Materials-Lactose was purchased from Janssen Chimica (Beerse, Belgium); oligomannoses (␣2 mannobiose, ␣3 mannobiose, and ␣6 mannobiose) were from Dextra Laboratories (Reading, UK). Lewis a , Lewis x , and Lewis b oligosaccharides were kindly donated by Gérard Strecker (F-Lille). Flu-neoglycoproteins were prepared by coupling bovine serum albumin (BSA) with phenylisothiocyanate monosaccharides and disaccharides and labeled with fluorescein isothiocyanate (17, 18) . The number of sugar residues bound per BSA, determined by the resorcinol sulfuric acid micromethod (19) , under conditions of optimal affinity and specificity, was found to be 25 Ϯ 3. In addition, to assess the clustering effect, Man-BSA containing about 17 mannose residues was also used.
Chromatography-Conjugates were purified by gel filtration on a column (2 ϫ 45 cm) of either Trisacryl GF05 (Biosepra, Villeneuve-laGarenne, France), stabilized and eluted with distilled water containing 5% n-butanol, or BioGel (P2, P4, or P6 from Bio-Rad, Oxfordshire, England), stabilized and eluted with 50 mM acetic acid. The flow rate was 0.35 ml/min.
High performance liquid chromatography (HPLC) was performed on a Waters 2690 apparatus (Milford, MA) linked to a Waters 2996 photodiode array detector. For glycosynthon analysis, a 5-m LC-NH 2 (4.6 ϫ 250 mm) column was stabilized and eluted with acetonitrile/ water (84/16, v/v) at 35°C. The flow rate was 1 ml/min. For glycocluster analysis, a Vydac 5-m C 4 (4.6 ϫ 250 mm) column (Hesperia, CA) was stabilized at 35°C in the starting eluent: 2% of solvent B (acetonitrile 95%/water 5%/trifluoroacetic acid 0.1%) in solvent A (water 95%/acetonitrile 5%/trifluoroacetic acid 0.1%). Upon injection, the compounds were eluted using this mixture for 5 min and then a linear gradient of 2-15% solvent B in solvent A over 15 min. The flow rate was 1 ml/min.
1 H NMR Spectroscopy-For 1 H NMR analysis, compounds were dissolved at room temperature in deuterated water, once with D 2 O containing 99.9% D, and, after freeze-drying, with D 2 O containing 99.96% D (Sigma).
1 H NMR spectroscopy was performed at 300 K with a Varian Unity 500 MHz NMR spectrometer.
Synthesis and Characterization of Oligosaccharyl-Glp-␤Ala-OHThe first step was to synthesize the glycosynthon oligosaccharyl-Glp␤Ala-OH (15) in a one-pot, two-step reaction, by coupling an oligosaccharide with a protected dipeptide H-Glu-␤Ala-OBzl in the presence of imidazole followed by intramolecular acylation to stabilize the glycosylamine formed. After purification on Trisacryl column, the glycosynthon was deprotected by catalytic hydrogenation. The glycosynthons synthesized from lactose and mannobioses, Man␣2Man, Man␣3Man, and Man␣6Man, are fully described in Frison et al. (14) . The same procedures were followed for the synthesis of glycosynthons from Lewis a /Lewis x oligosaccharides and Lewis b oligosaccharide. Lewis a and Lewis x oligosaccharides (Gal␤3(Fuc␣4)GlcNAc␤3Gal␤4Glc and Gal␤4(Fuc␣3)GlcNAc␤3Gal␤4Glc) ( Fig. 1) were isolated as a mixture from biological fluids that included human milk. However, because they behave almost identically in most chromatographic systems, it is difficult to obtain a pure preparation of each. Remarkably, we found that they were easily separated by HPLC as glycosynthons (Gal␤3(Fuc␣4)GlcNAc␤3Gal␤4Glc-Glp-␤Ala-OBzl and Gal␤4(Fuc␣3)GlcNAc␤3Gal␤4G-lc-Glp-␤Ala-OBzl) after substitution of the terminal reducing sugar by a short peptide (pyroglutamyl-␤-alanyl-O-benzyl ester) (20) . Consequently, we were able to prepare and use the pure Lewis a and Lewis ␣-and ⑀-amino groups of the lysine residues of a peptide core Lys n -AlaCys(SPy)NH 2 (with n ϭ 1, 2, 3, 4 or 5) (Fig. 2) . The resulting glycoclusters, oligosaccharyl-Glp-␤Ala-[Lys(oligosaccharyl-Glp-␤Ala-)] n -AlaCys(SPy)-NH 2 , were purified on a BioGel column and analyzed by HPLC and by 1 H NMR to control the substitution. The cysteine residue was used to label the glycocluster: the thiol group was made free in the presence of Tris-(2-catboxyethyl)phosphine and then substituted by reaction with iodoacetamidofluorescein under nitrogen in a 50 mM sodium phosphate buffer (at pH 7.2, to avoid the formation of dimers), leading to oligosaccharyl-Glp-␤Ala-[Lys(oligosaccharyl-Glp-␤Ala-)] n -Ala-Cys(Flu)-NH 2 . All molecules were characterized by HPLC and 1 H NMR. Production of Cells Expressing DC-SIGN or the Mannose ReceptorHeLa cells transiently expressing DC-SIGN were produced by transfection of full-length cDNA (21) , tagged with an AU1 epitope tag introduced in the extracellular 3Ј region of the plasmid. HeLa human carcinoma cells (Eurobio, Les Ulis, France) were cultured in Dulbecco's modified Eagle's medium (DMEM, Invitrogen, Paisley, Scotland) supplemented with 10% heat-inactivated fetal bovine serum (Clontech), 2 mM L-alanylglutamine (Invitrogen), 10 units/ml penicillin, and 10 g/ml streptomycin (Invitrogen) (complete medium). HeLa cells or rat fibroblasts were seeded 1 day before transfection at 1.5 ϫ 10 5 cells per well in a 24-well culture plate or 10 6 cells in a 6-cm diameter Petri dish. ExGen 500 (Euromedex, Souffelweyersheim, France), a linear polyethyleneimine (22 kDa), was used to transfect the cells (22) . 10 l of ExGen diluted in 40 l of 150 mM NaCl was added dropwise under vortex to plasmid DNA (1 g from a 1 mg/ml DNA solution, diluted in 50 l of 150 mM NaCl). This mixture was kept for 10 min at room temperature to allow complex formation, then 100 l of serum-free DMEM medium was added, and this final mixture was poured into each well (1.5 cm in diameter). Following incubation for 3 h at 37°C in a CO 2 humidified atmosphere, the medium was discarded, complete medium containing serum was added, and cells were further incubated for 48 h at 37°C. In some experiments a large number of cells was transfected in Petri dishes, and, after a 24-h incubation, cells were released by trypsin-EDTA treatment; 2 ϫ 10 5 cells were either put in 24-well plates for flow cytometry analysis or on glass coverslips for confocal microscopy analysis and incubated for a further 24 h before uptake experiments. As a control of transfected cells, we used cDNA (pMR60⌬ 378 Myc-His) (23) encoding the myc-tagged truncated intracellular mannose-specific lectin MR60/ERGIC-53 (24) .
Production of stably transfected rat fibroblast cell lines expressing the human mannose receptor using retroviral infection has been described previously (25) . The cell line used in this study was produced using the same method. Mannose receptor expression in this line is approximately twice as high as in the transfected cell line described originally, as assessed by pulse labeling and immunoprecipitation with an anti-mannose receptor antibody and uptake of 125 I-labeled mannose-BSA. Dendritophages-These were kindly provided by J. P. Abastado (Immuno Designed Molecules, Paris). Briefly, peripheral blood mononuclear cells were obtained from apheresis from healthy volunteers (on average, 10 10 peripheral blood mononuclear cells), washed three times in phosphate-buffered saline (PBS), and cultured for 7 days in nonadherent hydrophobic bags (Sdedim, Aubagne, France) in serum-free AIM-V medium (VacCell medium, IDM Life Technologies, France), which was supplemented with 500 units/ml GM-CSF and 50 ng/ml IL-13, at a density of 5 ϫ 10 6 cells/ml. Fresh IL-13 was added on day 4 of culture. On day 7, dendritophages were isolated by elutriation (26) . The purity of dendritophages ranged from 75 to 95%, and their viability was in all cases greater than 95%. Dendritophages were plated at 4 ϫ 10 5 per well in 24-well culture plates and used 3 days after elutriation. Flow Cytometry Analysis of Endocytosis-Plated cells were incubated for 2 h at 37°C in complete culture medium in the presence of the fluorescein-labeled conjugates (1.33 nM to 1.3 M (0.1-100 g/ml) Fluneoglycoprotein, 1-10 M glycoclusters). After washing in PBS, cells were either recovered by trypsin-EDTA treatment for direct flow cytometry analysis or further incubated with a specific antibody to visualize the membrane lectin (see below, immunofluorescence).
Cell suspensions were incubated for a further 30 min at 4°C in the presence or in the absence of 50 M monensin (18, 27) , and the cellassociated fluorescence was determined by flow cytometry. To look for specific uptake of fluoresceinated conjugates, cells were preincubated for 30 min in the presence of fluorescein-free Man-BSA (1 mg/ml) as previously described (7), followed by incubation at 37°C for 2 h in the presence of both 1 mg/ml fluorescein-free Man-BSA and a fluoresceinlabeled conjugate. Cell-associated fluorescence was assessed using a BD-LSR flow cytometer, and the data were analyzed with Cell Quest software (BD Biosciences). In the case of DC-SIGN, the fluorescein fluorescence intensity reported is that of cells expressing DC-SIGN as evidenced by their labeling with an anti-AU1 antibody.
Immunofluorescence-DC-SIGN-expressing cells were visualized using mouse monoclonal anti-AU1 epitope tag (RDI, Flanders). Cell surface DC-SIGN was labeled either by incubating living cells or cells fixed with 2% (w/v) paraformaldehyde with anti-AU1 (1/300, 45 min at room temperature) followed by incubation with R-phycoerythrin conjugated to a goat anti-mouse immunoglobulin-specific polyclonal antibody (1/ 2 C. E. Napper and M. E. Taylor, unpublished observations. 100) (BD Biosciences/Pharmingen, labeled anti-mouse immunoglobulin) for flow cytometry analysis or rhodamine Red TM -X conjugated to an AffiniPure F(abЈ) 2 fragment goat anti-mouse IgG(HϩL) antibody (1/ 100) for confocal microscopy analysis. The myc-tagged truncated MR60 was detected using anti-myc antibodies (Invitrogen, Leek, The Netherlands) following fixation and permeabilization of cells with saponin (0.1% saponin in PBS-glycine, 20 min at room temperature) (23) .
Confocal Microscopy Analysis-Cells were fixed at 37°C in PBS containing 2% paraformaldehyde for 20 min. Coverslips were mounted on slides in a PBS/glycerol mixture (1:1 v/v) containing 1% 1,4-diazabicyclo[2.2.2]octane (DABCO) as an anti-fading agent (28) . Cell fluorescence was analyzed with a confocal imaging system MRC-1024 (Bio-Rad, Ivry sur Seine, France) equipped with a Nikon Optiphot epifluorescence microscope (Nikon, Tokyo, Japan) and a ϫ60 Planapo objective (numerical aperture 1.4). The krypton/argon laser was tuned to produce both 488-nm (fluorescein excitation) and 568-nm (rhodamine excitation) wavelengths. Images were recorded with a Kalman filter average of 10 -15 images and treated with Adobe Photoshop software.
Analysis of Glycocluster Binding to Soluble Mannose Receptor and DC-SIGN Fragments by Surface Plasmon
Resonance-A soluble fragment of the human mannose receptor consisting of the eight C-type CRDs (MMR1-8) was produced in Chinese hamster ovary cells as described previously (29, 30) . This fragment of the receptor contains all of the domains necessary for Ca 2ϩ -dependent binding of Man/GlcNAc/ Fuc-terminated glycoconjugates and binds such ligands as well as the whole receptor does (29, 31) . MMR1-8 was isolated from the medium by affinity chromatography on mannose-substituted Sepharose. A soluble fragment of DC-SIGN consisting of the whole extracellular region was produced by bacterial expression as described previously (11) . Protein was purified by affinity chromatography and ion exchange chromatography.
To compare the affinities of different glycoclusters for the mannose receptor and DC-SIGN, we chose to immobilize the lectins, because previous studies (32) have shown that, when a lectin is immobilized, the affinity constant calculated is in good agreement with values obtained using classic methods in solution. Soluble MMR1-8 and DC-SIGN proteins were linked to the sensor chip CM5, starting with lectin concentrations of 10 g/ml in 10 mM sodium acetate at pH 4.5. Efficient fixation was indicated by a large increase in the refractive index: ⌬RU ϭ 5000 for MMR1-8 and ⌬RU ϭ 2000 for DC-SIGN. The neoglycoproteins (Man-BSA or Fuc-BSA) in the absence or in the presence of inhibitors were injected in the running buffer (pH 7.4, 10 mM HEPES, 1 mM CaCl 2 , 1 mM MgCl 2 , 150 mM NaCl, 17 mM NaN 3 , 0.5% P20 (BIAcore surfactant)) at a flow rate of 20 l/min to avoid mass transfer limitations. Regeneration of the chip was achieved by adding 0.3 M ␣-methylmannopyranoside to the running buffer for all flow cells. Inhibition constants were derived from experiments using a solution of glycocluster (0.25-25 M concentration range), containing 0.125 M Man-BSA or Fuc-BSA neoglycoprotein. These neoglycoprotein concentrations were those that gave the half-maximal value of resonance units (RU max /2). The procedure to determine RU max as well as the equations used to analyze row data are fully described in Ref. 33 . The number of resonance units (RUs) was obtained from the sensorgrams; RU max and the affinity constant K were deduced from the linear transformation
where g is the concentration of the neoglycoprotein expressed as mol⅐liter Ϫ1 . The factor ␣ stands for the Sips coefficient (34), which takes into account the avidity effect as well as the heterogeneity of the neoglycoprotein (Man-BSA and Fuc-BSA containing between 20 and 30 sugar units) and/or of the surface density of the lectin immobilized on the chip. Data were fitted into a straight line corresponding to the equation,
where i is the concentration of the glycocluster inhibitor expressed as mol⅐liter Ϫ1 , and K a is the association constant of the glycocluster tested.
RESULTS

Neoglycoprotein Uptake by Cells Expressing Either the Mannose
Receptor or DC-SIGN-Our previous studies have demonstrated the presence of mannose-specific membrane lectins on the surface of human dendritic cells, but the molecules responsible for this binding were not characterized (7) . Using flow cytometry analysis and a panel of fluorescein-labeled neoglycoproteins bearing 25 sugar units (on average), we showed that Fuc-BSA and Man-BSA are the neoglycoproteins most efficiently internalized and Lac-BSA one of the least efficiently internalized (7). Thus, we decided to study the uptake of such neoglycoproteins by cells expressing either the mannose receptor or DC-SIGN to get more precise insights than can be obtained using immature dendritic cells that are known to express both lectins.
Rat fibroblast-derived cell lines stably transfected with the mannose receptor have previously been shown to mediate efficient endocytosis of 125 I-labeled mannose-BSA (25, 35) . Consistent with these results, rat fibroblasts expressing the mannose receptor efficiently took up fluorescein-labeled mannose-BSA bearing on average 25 mannose residues (Flu,Man 25 -BSA) (Fig. 3) . Fucose-BSA (Flu,Fuc 25 -BSA) was also taken up by the mannose receptor-expressing cells, but the cells did not endocytose lactose-BSA (Flu,Lac 25 -BSA). The ligands of the mannose receptor are known to be internalized into an acidic compartment (see Ref. 36 for a review) . This finding was confirmed by the 10-to 20-fold fluorescence intensity increase seen following monensin postincubation of cells expressing the mannose receptor that had previously been incubated at 37°C for 2 h with Flu,Man 25 -BSA or Flu,Fuc 25 -BSA. Monensin is known to neutralize intracellular acidic compartments allowing the recovery of fluorescein fluorescence that is quenched in an acidic environment (37) . Thus, the increase in fluorescence intensity seen upon monensin treatment indicated that Flu, Man 25 -BSA and Flu,Fuc 25 -BSA internalized by the mannose receptor are routed to an acidic compartment.
We have previously shown, using different types of cells, that neoglycoproteins bearing about 25 sugars are specifically recognized by endogenous lectins (18) . Higher substitution increases nonspecific binding, and lower substitution leads to inefficient neoglycoprotein binding and consequently to poor uptake by membrane lectins because of the loss of avidity (38) . Consistent with these results, in the case of cells expressing the mannose receptor, the cell fluorescence measured upon incubation at 37°C in the presence of Flu-neoglycoprotein and a postincubation at 4°C with monensin was higher with Flu, Man 25 -BSA (1.5-fold) than with Flu,Man 17 -BSA (data not shown). Neoglycoproteins were not internalized by rat fibroblasts transfected with an empty vector (data not shown).
Peripheral blood mononuclear cells differentiate into dendritic cells upon culture in the presence of GM-CSF and IL-4 (7) or into dendritophages upon culture in the presence of GM-CSF and Il-13 (13) . Both dendritic cells and dendritophages took up Flu,Fuc 25 -BSA and Flu,Man 25 -BSA with high efficiency, but the fluorescence increase induced by the monensin postincubation was limited (Fig. 3) . This weak fluorescence intensity increase may be related to localization in less acidic compartments. This difference may also be associated with the expression of DC-SIGN in addition to the mannose receptor. To shed light on this problem, we investigated the uptake of the same neoglycoproteins by HeLa cells or rat fibroblasts that transiently express DC-SIGN.
Based on specific immunolabeling, about 15% of the transfected HeLa cells expressed a large amount of DC-SIGN. These DC-SIGN-positive cells efficiently took up Flu,Man-BSA and Flu,Fuc-BSA (both bearing 25 sugar residues) (Fig. 3) . The uptake of Flu,Fuc-BSA was slightly higher than that of Flu, Man-BSA. Rat fibroblast-derived cells that express DC-SIGN took up both Flu,Fuc-BSA and Flu, Man-BSA but less efficiently (5-fold) than HeLa cells expressing DC-SIGN (data not shown). Nontransfected or mock transfected HeLa cells or rat fibroblasts that did not express DC-SIGN took up neither Flu, Man-BSA nor Flu,Fuc-BSA. These cells served as controls to validate the specific uptake of glycoconjugates. Dual-parameter analysis of Flu-neoglycoprotein uptake by cells expressing DC-SIGN showed that the highest neoglycoprotein uptake corresponds to the highest expression of DC-SIGN. It was noticeable that Flu,Lac-BSA was taken up poorly by HeLa cells transfected with DC-SIGN mirroring the low Flu,Lac-BSA uptake by mannose receptor-expressing cells and dendritophages (Fig. 3) . The fluorescence increase upon monensin treatment (about 5-fold) was lower with transfected cells expressing DC-SIGN than with the mannose receptor expressing cells (about 10-to 20-fold). This difference is likely to be related to the properties of the lectins, including their intracellular routing, rather than to the type of cells, because similar results were obtained with HeLa cells and rat fibroblasts.
Analysis by confocal microscopy revealed Flu,Man-BSA and Flu,Fuc-BSA inside all of the cells expressing the mannose receptor, with the cell population being quite homogenous (Fig.  4A) . The ligands were seen in numerous small vesicles located diffusely throughout the cytoplasm. Immunolabeling for DC-SIGN showed that only cells expressing DC-SIGN were able to internalize Flu,Man-BSA or Flu,Fuc-BSA (Figs. 4B and 5A). Untransfected HeLa cells showed no fluorescence. Similar results were obtained with untransfected rat fibroblasts (not shown). Cells expressing the myc-tagged MR60, the truncated intracellular mannose-specific lectin used as an alternative control, did not internalize Flu-neoglycoproteins (Fig. 5A ).
To eliminate cell surface binding, DC-SIGN-transfected cells were incubated at 4°C with Pronase after incubation with Flu-neoglycoproteins and before immunolabeling. The Pronase treatment appeared to clear off the surface-associated neoglycoprotein but not to impair the immunodetection of DC-SIGN. The merged images (Fig. 5B) clearly showed that both Flu, Man-BSA and Flu,Fuc-BSA were taken up by cells expressing DC-SIGN and were found in vesicles concentrated close to the nucleus.
Endocytosis of Dimannoside Glycoclusters by the Mannose Receptor-Uptake of glycoclusters made of disaccharides Man␣2Man, Man␣3Man, Man␣6Man, or Gal␤4Glc (lactose), by cells expressing membrane lectins has been investigated previously (14) . Monocyte-derived dendritophages took up glycoclusters containing four or five dimannosides, with Man␣6Man clusters taken up most efficiently, but they did not take up lactoside clusters. Using flow cytometry, similar re- sults were obtained here with fibroblasts expressing the mannose receptor. The series of Man␣6Man clusters was investigated first (Fig. 6A) . Upon incubation at 37°C with fluorescent glycoclusters, maximal fluorescence intensity was seen with (Man␣6Man) 4 Lys 3. Due to an avidity effect, the uptake greatly increases from mannosylated dilysine cluster (bearing three dimannosides) to trilysine clusters bearing four dimannosides, but uptake did not increase further with tetra and pentalysine conjugates. As for neoglycoproteins, the cell fluorescence measured upon incubation at 37°C for 2 h in the presence of Flu, mannoside clusters and for 30 min without the monensin treatment was low, whereas upon monensin postincubation the cell-associated fluorescence substantially increased.
Cells expressing the mannose receptor took up Man␣6Man clusters twice as efficiently as Man␣2Man or Man␣3Man clusters (Fig. 6B) . No significant uptake was detected with lactoside clusters. The dimannose cluster uptake was inhibited by coincubation in the presence of an excess of unlabeled Man 25 -BSA, with 90% inhibition achieved for cells coincubated with 1 M Flu,(Man␣6Man) 4 Lys 3 and 13.3 M (1 mg/ml) fluoresceinfree Man 25 -BSA.
Surprisingly, dimannoside clusters were not internalized by HeLa cells expressing DC-SIGN, although DC-SIGN-expressing cells internalized Flu,Man-BSA with high efficiency. The confocal analysis confirms the absence of uptake of dimannoside clusters, because no fluorescence was detected inside the cells upon incubation in the presence of up to 10 M Flu,(Man␣6Man) nϩ1 Lys n (n ϭ 3-5) (Fig. 4B) .
Endocytosis of Lewis Clusters-Because neoglycoproteins bearing fucosyl residues are quite efficiently recognized and endocytosed by dendritophages, dendritic cells as well as by transfected cells expressing either the mannose receptor or DC-SIGN, we decided to synthesize oligolysine clusters made of oligosaccharides containing fucose. The mixture of Lewis a and Lewis x pentasaccharides, isolated and purified as a mixture from milk and Lewis b hexasaccharide, were transformed into glycosynthons and were resolved by HPLC (20) . The mixture of Lewis a and Lewis x glycosynthons, the pure Lewis a and Lewis x glycosynthons, and Lewis b glycosynthons were separately coupled to trilysine or tetralysine. Uptake of the fluorescein-labeled conjugates was investigated in fibroblasts expressing the mannose receptor and in HeLa cells expressing DC-SIGN as well as in human dendritophages (Fig. 7) .
Endocytosis of Lewis glycosynthons, Flu,(Lewis a ) 4 Lys 3 , Flu,(Lewis x ) 4 Lys 3 , and Flu,(Lewis b ) 4 Lys 3 , by the mannose receptor-expressing cells was about 2.5-fold lower than that of Man␣6Man clusters. Although the dimannoside clusters were not taken up by cells expressing DC-SIGN, the Lewis clusters were taken up at a significant rate by cells expressing DC-SIGN. As it was the case with Flu-neoglycoprotein, the cell fluorescence of cells expressing DC-SIGN incubated with the Lewis clusters was lower than that obtained with cells expressing the mannose receptor. Lewis clusters were internalized into acidic vesicles as shown by the fluorescence increase upon monensin incubation (Fig. 7) . The Lewis x isomer was more efficiently taken up than the Lewis a in all cell types expressing mannose receptor, DC-SIGN, or both. Lewis clusters were also taken up by dendritophages but to a lower extent than Man␣6Man clusters (Fig. 7) . The uptake of fucose-containing oligosaccharide clusters by cells expressing DC-SIGN into intracellular vesicles was confirmed by confocal microscopy (Fig.  4) .
Surface Plasmon Resonance-Binding affinities of the neoglycoproteins for the mannose receptor and DC-SIGN were determined using surface plasmon resonance. A soluble fragment of the mannose receptor consisting of the eight C-type CRDs (MMR1-8) and the extracellular domain of DC-SIGN were immobilized on sensor chips, and binding affinities were measured using a range of neoglycoprotein concentrations, from 6.6 nM to 2.7 M (0.5-200 g/ml). BSA preparations bearing about 25 units of ␣Man, ␣LFuc, ␣Glc, ␣Gal, ␣Man6P, ␣GalNAc, Gal␤4Glc (Lac), or GlcNAc␤1,4GlcNAc were tested. Fuc-BSA and Man-BSA gave the highest increase in refractive index with MMR1-8 and DC-SIGN, with Fuc-BSA having a slightly better affinity than Man-BSA (Table I) The affinities of glycoclusters binding to MMR1-8 and DC SIGN were deduced from their inhibitory effect on the binding of Man-BSA on immobilized lectins (Table I ). The Sips coefficients, which depend on the degree of heterogeneity of the neoglycoprotein used as ligands and on the heterogeneity of the lectin on the sensor chip varied from 0.4 to 0.8. The dimannoside-based clusters have a high affinity for the mannose receptor but a low affinity for DC-SIGN. The affinity increases with the number of dimannose units bound to oligolysine and becomes optimal with three to four lysines per cluster; the affinity constant of the Man␣6Man cluster containing four dimanno- sides and three lysines was 6 ϫ 10 6 liter⅐mol Ϫ1 . The two other clusters synthesized from Man␣3Man and Man␣2Man had binding constants less than that of the Man␣6Man cluster. The affinity constants obtained by inhibition of Fuc-BSA binding were about 2-fold lower than those obtained by inhibition of the binding of Man-BSA. In contrast, Lewis clusters had a higher affinity for DC-SIGN than for the mannose receptor (Table I)w ith Lewis x and Lewis b being the best inhibitors.
DISCUSSION
This study showed that glycoclusters made of oligolysine substituted with appropriate sugars make effective ligands for the mannose receptor and DC-SIGN. The glycoclusters are easily synthesized and fully biodegradable (14) and thus may be appropriate for targeting to dendritic cells in human therapy. Analysis of endocytosis of fluorescein-labeled glycoclusters by cells expressing either DC-SIGN or the mannose receptor and measurement of the affinities of different glycoclusters for the purified lectins has provided information about the best ligands to use for targeting specifically to either DC-SIGN or the mannose receptor. In addition, the results give insights into binding and trafficking of glycoprotein ligands by each of these C-type lectins.
Our experiments with neoglycoproteins showed that both DC-SIGN and the mannose receptor are able to mediate endocytosis of Man 25 -BSA and Fuc 25 -BSA. The two receptors show different preferences for these neoglycoproteins. Man 25 -BSA is taken up more readily than Fuc 25 -BSA by the mannose receptor, whereas the opposite is true for DC-SIGN. The results suggest slight differences in the way these two receptors interact with fucose versus mannose. Uptake of neoglycoproteins by the mannose receptor is well documented, but there has been no previous demonstration of neoglycoprotein uptake mediated by DC-SIGN. In fact, previous experiments with mannose-BSA containing 15 mol of mannose failed to demonstrate endocytosis by DC-SIGN (12) . Lack of neoglycoprotein uptake by DC-SIGN in the previous study is likely to be due to the low substitution of mannose in the mannosylated BSA. Neoglycoproteins containing a low amount of sugar bind to lectins with low apparent affinity, because the sugar density on the protein surface is too low to induce a large avidity or cluster effect (38) . Indeed, in contrast to the efficient uptake of Man 25 -BSA, we found that a fluorescein-labeled mannosylated BSA containing only 17 mannose residues was taken up very poorly by DC-SIGN-transfected cells.
The small difference seen in the relative abilities of the mannose receptor and DC-SIGN to bind to Man-BSA versus Fuc-BSA is magnified when glycoclusters are used. Glycoclusters made of Man␣6Man disaccharides are very good ligands for the mannose receptor, but they do not bind to DC-SIGN, whereas glycoclusters made with Lewis oligosaccharides, which contain fucose, are good ligands for DC-SIGN. The in- ability of DC-SIGN to recognize the dimannoside clusters even though it can recognize single mannose residues on Man-BSA highlights differences in the spacing of the C-type CRDs in DC-SIGN compared with the mannose receptor. Presentation of the dimannosides bound to oligolysine must be inappropriate for binding to the CRDs clustered in the tetrameric DC-SIGN (11) but ideal for the linear arrangement of multiple CRDs in the single polypeptide of the mannose receptor (30) . The best dimannoside cluster ligands for the mannose receptor are those with Man␣6Man units bound to at least a trilysine core (Man␣6Man) 4 Lys 3 ; in agreement with the avidity effect of multivalent ligands (38, 39) , the maximal apparent affinity requires a minimum of four dimannosides. The finding that DC-SIGN does not bind to the dimannoside cluster ligands indicates that uptake of these ligands by dendritophages observed previously must be due to the mannose receptor (14) . Thus Man␣6Man glycoclusters could be used specifically to target the mannose receptor.
The results presented here also suggest that the mannose receptor and DC-SIGN might route ligands to different intracellular compartments. Cell-associated fluorescence increases following monensin postincubation when endocytosis of glycoclusters is measured in either cells expressing the mannose receptor or cells expressing DC-SIGN, but the increase is much greater for cells expressing the mannose receptor. Thus, although glycoclusters endocytosed by the mannose receptor end up in very acidic vesicles, glycoclusters taken up by DC-SIGN become localized in more neutral compartments. It is well known that mannose receptor-glycoconjugate complexes dissociate in early endosomes and that the released glycoconjugate is targeted to lysosomes while the receptor recycles to the cell surface (40) . In contrast, our results indicate that glycoconjugates taken up by DC-SIGN might not reach the lysosomes, or at least not as quickly as those taken up by the mannose receptor.
When endocytosis of ligands taken up both by cells expressing the mannose receptor and by cells expressing DC-SIGN is measured in dendritophages, the increase in cell-associated fluorescence following monensin treatment mirrors that seen for cells expressing DC-SIGN rather than that seen with cells expressing the mannose receptor. It appears, therefore, that, although both receptors are expressed on dendritic cells, the activity of DC-SIGN is predominant in these cells. Thus, the Lewis cluster ligands, particularly those containing Lewis x and Lewis b , which have high affinity for DC-SIGN, may be appropriate ligands for targeting to this receptor in dendritic cells. Investigations with the aim of determining the differential efficiency of these glycoclusters to target antigens will be the next step.
